Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 38

Sort by

Sort Order Select

Journal Articles

The α-emitter astatine-211 targeted to CD38 can eradicate multiple myeloma in a disseminated disease model

Shyril O’Steen, Melissa L. Comstock, Johnnie J. Orozco, Donald K. Hamlin, D. Scott Wilbur, Jon C. Jones, Aimee Kenoyer, Margaret E. Nartea, Yukang Lin, Brian W. Miller, Theodore A. Gooley, Sherilyn A. Tuazon, Brian G. Till, Ajay K. Gopal, Brenda M. Sandmaier, Oliver W. Press, Damian J. Green

Blood (2019) 134 (15): 1247–1256.

https://doi.org/10.1182/blood.2019001250

Published: 2019

Includes: Supplemental data

Journal Articles

CD38-bispecific antibody pretargeted radioimmunotherapy for multiple myeloma and other B-cell malignancies

Damian J. Green, Shyril O’Steen, Yukang Lin, Melissa L. Comstock, Aimee L. Kenoyer, Donald K. Hamlin, D. Scott Wilbur, Darrell R. Fisher, Margaret Nartea, Mark D. Hylarides, Ajay K. Gopal, Theodore A. Gooley, Johnnie J. Orozco, Brian G. Till, Kelly D. Orcutt, K. Dane Wittrup, Oliver W. Press

Blood (2018) 131 (6): 611–620.

https://doi.org/10.1182/blood-2017-09-807610

Published: 2018

Includes: Supplemental data

Journal Articles

Posttransplant feasibility study of nilotinib prophylaxis for high-risk Philadelphia chromosome positive leukemia

Paul A. Carpenter, Laura Johnston, Hugo F. Fernandez, Jerald P. Radich, Michael J. Mauro, Mary E. D. Flowers, Paul J. Martin, Theodore A. Gooley

Blood (2017) 130 (9): 1170–1172.

https://doi.org/10.1182/blood-2017-03-771121

Published: 2017

Includes: Supplemental data

Journal Articles

A Phase II Trial of Radioimmunotherapy-Based Autologous Transplantation with I-131 Tositumomab, Cyclophosphamide and Etoposide in Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Paul S Martin, MD, Isaac C Jenkins, MS, Theodore A Gooley, PhD, Damian J Green, MD, John M Pagel, MD PhD, Sally J Lundberg, RN, Lacey M Hedine, Joseph G Rajendran, MD, Andrew T Shields, MD, Darrell R Fisher, PhD, David G Maloney, MD PhD, Frederick R Appelbaum, MD, Ryan D Cassaday, MD, Oliver W Press, MD PhD, Ajay K. Gopal, MD

Blood (2015) 126 (23): 5502.

https://doi.org/10.1182/blood.V126.23.5502.5502

Published: 2015

Journal Articles

Pre-Transplant Expressions of Micrornas Are Associated with Both Comorbidity Burden and Mortality Risks in Patients (Pts) with Acute Leukemia (AL) in Complete Remission (CR) Given Allogeneic Hematopoietic Cell Transplantation (HCT)

Mohamed L. Sorror, MD MS, Theodore A Gooley, PhD, Kirsteen Maclean, PhD, Shamali Roy, PhD, Jesse Hubbard, Mario Marcondes, MD PhD, Beverly Torok-Storb, PhD, Tewari Muneesh, MD PhD

Blood (2015) 126 (23): 385.

https://doi.org/10.1182/blood.V126.23.385.385

Published: 2015

Journal Articles

Post-Hematopoietic Stem Cell Transplantation Minimal Residual Disease and Early Relapses in MDS and AML Evolving from MDS

Moreno Festuccia, MD, Kelsey Baker, Theodore A Gooley, PhD, Brenda M. Sandmaier, MD, Joachim Deeg, MD, Brent L Wood, MD PhD, Min Fang, MD PhD, Bart Lee Scott, MD

Blood (2015) 126 (23): 2019.

https://doi.org/10.1182/blood.V126.23.2019.2019

Published: 2015

Journal Articles

Astatine-211 conjugated to an anti-CD20 monoclonal antibody eradicates disseminated B-cell lymphoma in a mouse model

Blood (2015) 125 (13): 2111–2119.

https://doi.org/10.1182/blood-2014-11-612770

Published: 2015

Includes: Supplemental data

Journal Articles

HLA-C expression levels define permissible mismatches in hematopoietic cell transplantation

Blood (2014) 124 (26): 3996–4003.

https://doi.org/10.1182/blood-2014-09-599969

Published: 2014

Includes: Supplemental data

Journal Articles

Long Term Follow-up of High-Dose CD20-Targeted Radioimmunotherapy-Based Autologous Transplantation for Patients with Mantle Cell Lymphoma

Ryan D. Cassaday, MD, Philip A. Stevenson, MS, Theodore A. Gooley, PhD, Thomas Chauncey, MD PhD, John Pagel, MD PhD, Brian G. Till, MD, Mary Philip, MD PhD, Johnnie J. Orozco, MD PhD, William I. Bensinger, MD, Leona Holmberg, MD PhD, Andrei R. Shustov, MD, Damian J. Green, MD, Stephen D. Smith, MD, Edward N. Libby, MD, David G Maloney, MDPhD, Lorinda A. Soma, MD, Oliver W. Press, MD PhD, Ajay K. Gopal, MD

Blood (2014) 124 (21): 3967.

https://doi.org/10.1182/blood.V124.21.3967.3967

Published: 2014

Journal Articles

Pretransplant comorbidities predict severity of acute graft-versus-host disease and subsequent mortality

Mohamed L. Sorror, Paul J. Martin, Rainer F. Storb, Smita Bhatia, Richard T. Maziarz, Michael A. Pulsipher, Michael B. Maris, Christopher Davis, H. Joachim Deeg, Stephanie J. Lee, David G. Maloney, Brenda M. Sandmaier, Frederick R. Appelbaum, Theodore A. Gooley

Blood (2014) 124 (2): 287–295.

https://doi.org/10.1182/blood-2014-01-550566

Published: 2014

Journal Articles

Bendamustine (Treanda®)-Based Regimens Are Effective In Mobilizing Peripheral Blood Hematopoietic Stem Cells For Autologous Transplantation

Damian J. Green, MD, William I. Bensinger, MD, Leona Holmberg, MD, PhD, Theodore A. Gooley, PhD, Brian G. Till, MD, Lihua Elizabeth Budde, MD, PhD, John M. Pagel, MD, PhD, Shani L. Frayo, BS, Jennifer E. Roden, Lacey M. Hedin, Malcolm Mack, Oliver W. Press, MD, PhD, Ajay K. Gopal, MD

Blood (2013) 122 (21): 2033.

https://doi.org/10.1182/blood.V122.21.2033.2033

Published: 2013

Journal Articles

A Phase I Study Of Myeloablative Radioimmunotherapy Using Iodine-131 Anti-CD45 Antibody Followed By Autologous Stem Cell Transplantation For High-Risk B-Cell and T-Cell Non-Hodgkin Lymphoma and Hodgkin Lymphoma

Ryan D. Cassaday, MD, Oliver W. Press, MD, PhD, John M. Pagel, MD, PhD, Joseph G. Rajendran, MD, Theodore A. Gooley, PhD, Darrell R. Fisher, PhD, Sally J. Lundberg, Lacey M. Hedin, Andrew T. Shields, MD, Damian J. Green, MD, Robert S. Miyaoka, PhD, Frederick R. Appelbaum, MD, Ajay K. Gopal, MD

Blood (2013) 122 (21): 3333.

https://doi.org/10.1182/blood.V122.21.3333.3333

Published: 2013

Journal Articles

Anti-CD38 Pretargeted Radioimmunotherapy Eradicates Multiple Myeloma Xenografts In a Murine Model

Damian J. Green, MD, Jon C. Jones, Mark D. Hylarides, PhD, Donald K. Hamlin, BS, D Scott Wilbur, PhD, Yukang Lin, PhD, Aimee L. Kenoyer, BS, Shani L. Frayo, BS, William I. Bensinger, MD, Ajay K. Gopal, MD, Johnnie J. Orozco, MD, PhD, Theodore A. Gooley, PhD, Brent L. Wood, MD, PhD, John M. Pagel, MD, PhD, Oliver W. Press, MD, PhD

Blood (2013) 122 (21): 882.

https://doi.org/10.1182/blood.V122.21.882.882

Published: 2013

Journal Articles

Myeloablative Umbilical Cord Blood Transplantation for Hematologic Malignancies Is Comparable to Unrelated Donor Transplantation: A Retrospective Single-Center Study

Filippo Milano, MD, PhD, Theodore A. Gooley, PhD, Paul O'Donnell, MD, PhD, Boglarka Gyurkocza, M.D., H. Joachim Deeg, MD, Anne Woolfrey, MD, Frederick R. Appelbaum, MD, Colleen Delaney, MD, MSc

Blood (2012) 120 (21): 1995.

https://doi.org/10.1182/blood.V120.21.1995.1995

Published: 2012

Journal Articles

Bendamustine (Treanda®), Etoposide and Dexamethasone (BED) Followed by GCSF Effectively Mobilizes Autologous Peripheral Blood Hematopoietic Stem Cells

Damian J. Green, MD, William I. Bensinger, MD, Leona Holmberg, MD, PhD, Theodore A. Gooley, PhD, Brian G. Till, MD, Lihua Elizabeth Budde, MD, PhD, Shani L. Frayo, BS, Jennifer E. Roden, Lacey Hedin, Oliver W. Press, MD, PhD, Ajay K. Gopal, MD

Blood (2012) 120 (21): 4126.

https://doi.org/10.1182/blood.V120.21.4126.4126

Published: 2012

Journal Articles

Anti-CD38 Pretargeted Radioimmunotherapy Demonstrates Therapeutic Efficacy In a Human Multiple Myeloma Mouse Xenograft Model

Damian J. Green, MD, Nural N. Orgun, Mark D. Hylarides, PhD, John M. Pagel, MD, PhD, Donald K. Hamlin, D. Scott Wilbur, PhD, Yukang Lin, PhD, Amiee L. Kenoyer, Shani L. Frayo, BS, William I. Bensinger, MD, Ajay K. Gopal, MD, Johnnie J. Orozco, MD, PhD, Theodore A. Gooley, PhD, Brent L. Wood, MD, PhD, Oliver W. Press, MD, PhD

Blood (2011) 118 (21): 1842.

https://doi.org/10.1182/blood.V118.21.1842.1842

Published: 2011

Journal Articles

Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood

Claudio G. Brunstein, Jonathan A. Gutman, Daniel J. Weisdorf, Ann E. Woolfrey, Todd E. DeFor, Theodore A. Gooley, Michael R. Verneris, Frederick R. Appelbaum, John E. Wagner, Colleen Delaney

Blood (2010) 116 (22): 4693–4699.

https://doi.org/10.1182/blood-2010-05-285304

Published: 2010

Journal Articles

Differential Gene Expression Associated with Chronic Myeloid Leukemia (CML) Progression Predicts Relapse and Survival Prior to Allogeneic Transplantation In Chronic Phase CML Patients

Vivian G. Oehler, MD, KaYee Yeung, PhD, Ailin Zhang, PhD, Theodore A. Gooley, PhD, Jerald P. Radich, MD

Blood (2010) 116 (21): 3507.

https://doi.org/10.1182/blood.V116.21.3507.3507

Published: 2010

Journal Articles

The helix-loop-helix transcription factor TWIST is dysregulated in myelodysplastic syndromes

Xiang Li, A. Mario Marcondes, Theodore A. Gooley, H. Joachim Deeg

Blood (2010) 116 (13): 2304–2314.

https://doi.org/10.1182/blood-2009-09-242313

Published: 2010

Includes: Supplemental data

Journal Articles

Allogeneic hematopoietic cell transplantation after conditioning with 131 I–anti-CD45 antibody plus fludarabine and low-dose total body irradiation for elderly patients with advanced acute myeloid leukemia or high-risk myelodysplastic syndrome

John M. Pagel, Theodore A. Gooley, Joseph Rajendran, Darrell R. Fisher, Wendy A. Wilson, Brenda M. Sandmaier, Dana C. Matthews, H. Joachim Deeg, Ajay K. Gopal, Paul J. Martin, Rainer F. Storb, Oliver W. Press, Frederick R. Appelbaum

Blood (2009) 114 (27): 5444–5453.

https://doi.org/10.1182/blood-2009-03-213298

Published: 2009

NARROW

The α-emitter astatine-211 targeted to CD38 can eradicate multiple myeloma in a disseminated disease model

CD38-bispecific antibody pretargeted radioimmunotherapy for multiple myeloma and other B-cell malignancies

Posttransplant feasibility study of nilotinib prophylaxis for high-risk Philadelphia chromosome positive leukemia

A Phase II Trial of Radioimmunotherapy-Based Autologous Transplantation with I-131 Tositumomab, Cyclophosphamide and Etoposide in Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Pre-Transplant Expressions of Micrornas Are Associated with Both Comorbidity Burden and Mortality Risks in Patients (Pts) with Acute Leukemia (AL) in Complete Remission (CR) Given Allogeneic Hematopoietic Cell Transplantation (HCT)

Post-Hematopoietic Stem Cell Transplantation Minimal Residual Disease and Early Relapses in MDS and AML Evolving from MDS

Astatine-211 conjugated to an anti-CD20 monoclonal antibody eradicates disseminated B-cell lymphoma in a mouse model

HLA-C expression levels define permissible mismatches in hematopoietic cell transplantation

Long Term Follow-up of High-Dose CD20-Targeted Radioimmunotherapy-Based Autologous Transplantation for Patients with Mantle Cell Lymphoma

Pretransplant comorbidities predict severity of acute graft-versus-host disease and subsequent mortality

Bendamustine (Treanda®)-Based Regimens Are Effective In Mobilizing Peripheral Blood Hematopoietic Stem Cells For Autologous Transplantation

A Phase I Study Of Myeloablative Radioimmunotherapy Using Iodine-131 Anti-CD45 Antibody Followed By Autologous Stem Cell Transplantation For High-Risk B-Cell and T-Cell Non-Hodgkin Lymphoma and Hodgkin Lymphoma

Anti-CD38 Pretargeted Radioimmunotherapy Eradicates Multiple Myeloma Xenografts In a Murine Model

Myeloablative Umbilical Cord Blood Transplantation for Hematologic Malignancies Is Comparable to Unrelated Donor Transplantation: A Retrospective Single-Center Study

Bendamustine (Treanda®), Etoposide and Dexamethasone (BED) Followed by GCSF Effectively Mobilizes Autologous Peripheral Blood Hematopoietic Stem Cells

Anti-CD38 Pretargeted Radioimmunotherapy Demonstrates Therapeutic Efficacy In a Human Multiple Myeloma Mouse Xenograft Model

Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood

Differential Gene Expression Associated with Chronic Myeloid Leukemia (CML) Progression Predicts Relapse and Survival Prior to Allogeneic Transplantation In Chronic Phase CML Patients

The helix-loop-helix transcription factor TWIST is dysregulated in myelodysplastic syndromes

Allogeneic hematopoietic cell transplantation after conditioning with 131 I–anti-CD45 antibody plus fludarabine and low-dose total body irradiation for elderly patients with advanced acute myeloid leukemia or high-risk myelodysplastic syndrome

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only